comparemela.com
Home
Live Updates
Adrian Kemp - Breaking News
Pages:
19
20
21
22
23
24
25
Latest Breaking News On - Adrian kemp - Page 18 : comparemela.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Evusheld approved for COVID-19 in Japan
Investegate announcements from AstraZeneca PLC, Evusheld approved for COVID-19 in Japan
United kingdom
Nat microbiol
Kazuhiro tateda
Itaru matsumura
Tixagevimab cilgavimab
Astrazeneca evusheld
Adrian kemp
Department of defense
Department of microbiology
Japan ministry of health
Vector engineering lab
Department of health
Nuclear defense
Biomedical advanced research
Human services
Drug administration
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Tagrisso approved in Japan for early lung cancer
Investegate announcements from AstraZeneca PLC, Tagrisso approved in Japan for early lung cancer
United states
United kingdom
Dave fredrickson
Masahiro tsuboi
Daiichi sankyo
Thorac onc
Astrazeneca tagrisso
Adrian kemp
Le chevalier
Company on twitter
International agency for research on cancer
Department of thoracic surgery oncology
National cancer center hospital
Collaborative group
Single institution study
Archives pathology lab
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Ultomiris approved in Japan for gMG
Investegate announcements from AstraZeneca PLC, Ultomiris approved in Japan for gMG
United states
United kingdom
Marc dunoyer
Hiroyuki murai
Adrian kemp
School of medicine
National organization for rare disorders
Department of neurology
International university of health
Alexion pharmaceuticals inc
Japanese ministry of health
Investor relations team
European union
National institutes of neurological disorders
Devices agency
Japan pharmaceuticals
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza granted FDA priority review for PROpel
Investegate announcements from AstraZeneca PLC, Lynparza granted FDA priority review for PROpel
United kingdom
United states
Eliav barr
Adrian kemp
Susan galbraith
Company on twitter
American society of clinical oncology
International journal of clinical practice
Drug administration
Merck co inc
Research laboratories
Investor relations team
Head of global clinical development
Priority review
New drug application
Prescription drug user fee act
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Enhertu granted Priority Review for HER2-low mBC
Investegate announcements from AstraZeneca PLC, Enhertu granted Priority Review for HER2-low mBC
United kingdom
United states
Daiichi sankyo enhertu
Daiichi sankyo
Ken takeshita
Trastuzumab deruxtecan
Adrian kemp
Susan galbraith
Centers for disease
Daiichi sankyo company
Arch pathol lab
Drug administration
American society of clinical oncology annual meetingand
Merck co inc
Company on twitter astrazeneca
Investor relations team
vimarsana © 2020. All Rights Reserved.